Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Suzhou Basecare MedicalHKSE:02170 70 Quick Ratio is 3.45 as of Dec. 2025, which is 24% below its 10-year median of 4.51. GuruFocus rates HKSE:02170 with a GF Score™ of 70/100 and a GF Value™ of HK$2.93 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Suzhou Basecare Medical ranks better than 72.3% on this metric.
Suzhou Basecare Medical has a quick ratio of 3.45. It generally indicates good short-term financial strength.
The historical rank and industry rank for Suzhou Basecare Medical's Quick Ratio or its related term are showing as below:
HKSE:02170'
s Quick Ratio Range Over the Past 10 Years
Min: 1.85 Med: 4.51 Max: 27.67
Current: 3.45
During the past 8 years, Suzhou Basecare Medical's highest Quick Ratio was 27.67. The lowest was 1.85. And the median was 4.51.
HKSE:02170's Quick Ratio is ranked better than 72.3% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.92
vs HKSE:02170: 3.45
Suzhou Basecare Medical (HKSE:02170) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Suzhou Basecare Medical Quick Ratio Related Terms
Suzhou Basecare Medical Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02170 vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, Suzhou Basecare Medical's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzhou Basecare Medical Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Suzhou Basecare Medical's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Suzhou Basecare Medical's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Basecare Medical (HKSE:02170) has a Quick Ratio of 3.45 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Suzhou Basecare Medical and its competitors. This is 24% below median its historical median of 4.51. Over the past decade, Suzhou Basecare Medical's Quick Ratio has ranged from 1.85 to 27.67. According to the industry distribution chart, Suzhou Basecare Medical ranks #236 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 27.7%.
Is Suzhou Basecare Medical's Quick Ratio too high?
Suzhou Basecare Medical's current Quick Ratio of 3.45 is 24% below median its 10-year median of 4.51. Over the past 10 years, this metric has ranged from a low of 1.85 to a high of 27.67. The Medical Devices & Instruments industry median Quick Ratio is 1.92. Suzhou Basecare Medical's value of 3.45 is 79.7% above this industry median. Based on the distribution chart, Suzhou Basecare Medical ranks #236 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Suzhou Basecare Medical has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Suzhou Basecare Medical's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Suzhou Basecare Medical ranks #236 out of 852 companies for Quick Ratio. This puts Suzhou Basecare Medical in the upper half of its industry. The industry median Quick Ratio is 1.92. Suzhou Basecare Medical's value of 3.45 is 79.7% above this benchmark. Historically, Suzhou Basecare Medical's own Quick Ratio has ranged from 1.85 to 27.67 over the past decade. While the company's 10-year median is 4.51 vs. the industry median of 1.92, Suzhou Basecare Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.92, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzhou Basecare Medical's current Quick Ratio of 3.45 is 79.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Suzhou Basecare Medical and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzhou Basecare Medical's current Quick Ratio is 3.45, which is 24% below median its own 10-year median of 4.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Basecare Medical stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Basecare Medical (HKSE:02170) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.93, compared to a current price of HK$1.40 — trading 52.2% below its estimated fair value. The current Quick Ratio is 3.45, which is 24% below median its 10-year median of 4.51 and 79.7% above the Medical Devices & Instruments industry median of 1.92. Suzhou Basecare Medical's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Suzhou Basecare Medical (HKSE:02170), the current Quick Ratio is 3.45 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Suzhou Basecare Medical (HKSE:02170) Overvalued in 2026?
Based on GuruFocus' analysis, Suzhou Basecare Medical stock appears to be undervalued.
The current stock price of HK$1.40 is trading 52.2% below its estimated GF Value™ of HK$2.93.
GuruFocus considers Suzhou Basecare Medical to be Possible Value Trap.
Key valuation signals for HKSE:02170:
Quick Ratio: 3.45 (24% below median its 10-year median of 4.51)
GF Value™: HK$2.93 vs. price of HK$1.40 (52.2% below fair value)
Industry Position: 79.7% above the Medical Devices & Instruments median (#236 of 852)
No single metric tells the full story. See the HKSE:02170 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Suzhou Basecare Medical Corp Ltd is a medical device company based in China, operating in the field of assisted reproduction. It is engaged in the research, development, and provision of medical products and related software in the field of reproductive health, to enable more families to have children. The Group's product portfolio comprises Gems Sperm Wash Gradient Set, Gems Fertilisation Medium, Gavi Instrument, Geri Incubator, Cryostorage System, PGT-A kit, Self sperm testing device, Sperm quality analyser, Genie sequencer, and others. It generates maximum revenue from the sale of testing kits. The Group's reportable segments are: the PRC, which derives maximum revenue, and Australia. Geographically, it operates in the PRC, Europe, Asia (excluding the PRC), and other regions.
70GF Score
Get the complete analysis for HKSE:02170
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02170 has been successfully added to your 
